Title : Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage.

Pub. Date : 2019 May 21

PMID : 31113013






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 HSP90 inhibitors mainly bind to the ATP binding site of HSP90 and inhibit HSP90 activity, and these inhibitors can be distinguished as ansamycin and non-ansamycin depending on the structure. Rifabutin heat shock protein 90 alpha family class A member 1 Homo sapiens
2 HSP90 inhibitors mainly bind to the ATP binding site of HSP90 and inhibit HSP90 activity, and these inhibitors can be distinguished as ansamycin and non-ansamycin depending on the structure. Rifabutin heat shock protein 90 alpha family class A member 1 Homo sapiens
3 HSP90 inhibitors mainly bind to the ATP binding site of HSP90 and inhibit HSP90 activity, and these inhibitors can be distinguished as ansamycin and non-ansamycin depending on the structure. Rifabutin heat shock protein 90 alpha family class A member 1 Homo sapiens
4 HSP90 inhibitors mainly bind to the ATP binding site of HSP90 and inhibit HSP90 activity, and these inhibitors can be distinguished as ansamycin and non-ansamycin depending on the structure. Rifabutin heat shock protein 90 alpha family class A member 1 Homo sapiens
5 HSP90 inhibitors mainly bind to the ATP binding site of HSP90 and inhibit HSP90 activity, and these inhibitors can be distinguished as ansamycin and non-ansamycin depending on the structure. Rifabutin heat shock protein 90 alpha family class A member 1 Homo sapiens
6 HSP90 inhibitors mainly bind to the ATP binding site of HSP90 and inhibit HSP90 activity, and these inhibitors can be distinguished as ansamycin and non-ansamycin depending on the structure. Rifabutin heat shock protein 90 alpha family class A member 1 Homo sapiens